Literature DB >> 23323914

Aspirin, PIK3CA mutation, and colorectal-cancer survival.

Antonio Viúdez, Irene Hernandez, Ruth Vera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23323914     DOI: 10.1056/NEJMc1214189

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.

Authors:  Nishi Kothari; Richard Kim; Robert N Jorissen; Jayesh Desai; Jeanne Tie; Hui-Li Wong; Ian Faragher; Ian Jones; Fiona L Day; Shan Li; Anuratha Sakthinandeswaren; Michelle Palmieri; Lara Lipton; Michael Schell; Jamie K Teer; David Shibata; Timothy Yeatman; Oliver M Sieber; Peter Gibbs; Ben Tran
Journal:  Acta Oncol       Date:  2014-12-31       Impact factor: 4.089

2.  Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.

Authors:  Kim M Keppler-Noreuil; Julie C Sapp; Marjorie J Lindhurst; Victoria E R Parker; Cathy Blumhorst; Thomas Darling; Laura L Tosi; Susan M Huson; Richard W Whitehouse; Eveliina Jakkula; Ian Grant; Meena Balasubramanian; Kate E Chandler; Jamie L Fraser; Zoran Gucev; Yanick J Crow; Leslie Manace Brennan; Robin Clark; Elizabeth A Sellars; Loren D M Pena; Vidya Krishnamurty; Andrew Shuen; Nancy Braverman; Michael L Cunningham; V Reid Sutton; Velibor Tasic; John M Graham; Joseph Geer; Alex Henderson; Robert K Semple; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2014-04-29       Impact factor: 2.802

3.  Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer.

Authors:  Weihua Li; Tian Qiu; Lin Dong; Fanshuang Zhang; Lei Guo; Jianming Ying
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.